These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 21453288)

  • 1. Properties of dopaminergic neurons in organotypic mesencephalic-striatal co-cultures--evidence for a facilitatory effect of dopamine on the glutamatergic input mediated by α-1 adrenergic receptors.
    Cucchiaroni ML; Freestone PS; Berretta N; Viscomi MT; Bisicchia E; Okano H; Molinari M; Bernardi G; Lipski J; Mercuri NB; Guatteo E
    Eur J Neurosci; 2011 May; 33(9):1622-36. PubMed ID: 21453288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic activation of the D2 autoreceptor inhibits both glutamate and dopamine synapse formation and alters the intrinsic properties of mesencephalic dopamine neurons in vitro.
    Fasano C; Kortleven C; Trudeau LE
    Eur J Neurosci; 2010 Nov; 32(9):1433-41. PubMed ID: 20846243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential electrophysiological properties of dopamine D1 and D2 receptor-containing striatal medium-sized spiny neurons.
    Cepeda C; André VM; Yamazaki I; Wu N; Kleiman-Weiner M; Levine MS
    Eur J Neurosci; 2008 Feb; 27(3):671-82. PubMed ID: 18279319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic development of prenatal ventral mesencephalon and striatum in organotypic co-cultures.
    Lyng GD; Snyder-Keller A; Seegal RF
    Brain Res; 2007 Feb; 1133(1):1-9. PubMed ID: 17196555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GABA(B) receptors at glutamatergic synapses in the rat striatum.
    Lacey CJ; Boyes J; Gerlach O; Chen L; Magill PJ; Bolam JP
    Neuroscience; 2005; 136(4):1083-95. PubMed ID: 16226840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in nigral NMDA and GABAA receptor control of the striatal dopamine level after repetitive exposures to nitrogen narcosis.
    Lavoute C; Weiss M; Rostain JC
    Exp Neurol; 2008 Jul; 212(1):63-70. PubMed ID: 18452916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homeostatic regulation of excitatory synapses on striatal medium spiny neurons expressing the D2 dopamine receptor.
    Thibault D; Giguère N; Loustalot F; Bourque MJ; Ducrot C; El Mestikawy S; Trudeau LÉ
    Brain Struct Funct; 2016 May; 221(4):2093-107. PubMed ID: 25782435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced glutamatergic phenotype of mesencephalic dopamine neurons after neonatal 6-hydroxydopamine lesion.
    Dal Bo G; Bérubé-Carrière N; Mendez JA; Leo D; Riad M; Descarries L; Lévesque D; Trudeau LE
    Neuroscience; 2008 Sep; 156(1):59-70. PubMed ID: 18706980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine depresses melanin concentrating hormone neuronal activity through multiple effects on α2-noradrenergic, D1 and D2-like dopaminergic receptors.
    Conductier G; Nahon JL; Guyon A
    Neuroscience; 2011 Mar; 178():89-100. PubMed ID: 21262322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional alterations of the dopaminergic and glutamatergic systems in spontaneous α-synuclein overexpressing rats.
    Guatteo E; Rizzo FR; Federici M; Cordella A; Ledonne A; Latini L; Nobili A; Viscomi MT; Biamonte F; Landrock KK; Martini A; Aversa D; Schepisi C; D'Amelio M; Berretta N; Mercuri NB
    Exp Neurol; 2017 Jan; 287(Pt 1):21-33. PubMed ID: 27771352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of TH-EGFP transgenic mice as a source of identified dopaminergic neurons for physiological studies in postnatal cell culture.
    Jomphe C; Bourque MJ; Fortin GD; St-Gelais F; Okano H; Kobayashi K; Trudeau LE
    J Neurosci Methods; 2005 Jul; 146(1):1-12. PubMed ID: 15935217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional properties and synaptic integration of genetically labelled dopaminergic neurons in intrastriatal grafts.
    Sørensen AT; Thompson L; Kirik D; Björklund A; Lindvall O; Kokaia M
    Eur J Neurosci; 2005 May; 21(10):2793-9. PubMed ID: 15926926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of NMDA and GABAA receptors in the inhibiting effect of 3 MPa nitrogen on striatal dopamine level.
    Lavoute C; Weiss M; Rostain JC
    Brain Res; 2007 Oct; 1176():37-44. PubMed ID: 17900538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine release in organotypic cultures of foetal mouse mesencephalon: effects of depolarizing agents, pargyline, nomifensine, tetrodotoxin and calcium.
    Larsen TR; Rossen S; Gramsbergen JB
    Eur J Neurosci; 2008 Aug; 28(3):569-76. PubMed ID: 18702728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamate in dopamine neurons: synaptic versus diffuse transmission.
    Descarries L; Bérubé-Carrière N; Riad M; Bo GD; Mendez JA; Trudeau LE
    Brain Res Rev; 2008 Aug; 58(2):290-302. PubMed ID: 18042492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Particular subpopulations of midbrain and hypothalamic dopamine neurons express vesicular glutamate transporter 2 in the rat brain.
    Kawano M; Kawasaki A; Sakata-Haga H; Fukui Y; Kawano H; Nogami H; Hisano S
    J Comp Neurol; 2006 Oct; 498(5):581-92. PubMed ID: 16917821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of GABAA receptor subunit variants in midbrain dopaminergic neurons.
    Okada H; Matsushita N; Kobayashi K; Kobayashi K
    J Neurochem; 2004 Apr; 89(1):7-14. PubMed ID: 15030384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine modulation of excitatory currents in the striatum is dictated by the expression of D1 or D2 receptors and modified by endocannabinoids.
    André VM; Cepeda C; Cummings DM; Jocoy EL; Fisher YE; William Yang X; Levine MS
    Eur J Neurosci; 2010 Jan; 31(1):14-28. PubMed ID: 20092552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic deletion of vesicular monoamine transporter-2 (VMAT2) reduces dopamine transporter activity in mesencephalic neurons in primary culture.
    Yamamoto H; Kamegaya E; Hagino Y; Imai K; Fujikawa A; Tamura K; Enokiya T; Yamamoto T; Takeshima T; Koga H; Uhl GR; Ikeda K; Sora I
    Neurochem Int; 2007; 51(2-4):237-44. PubMed ID: 17664021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The endocannabinoid 2-arachidonoylglycerol inhibits long-term potentiation of glutamatergic synapses onto ventral tegmental area dopamine neurons in mice.
    Kortleven C; Fasano C; Thibault D; Lacaille JC; Trudeau LE
    Eur J Neurosci; 2011 May; 33(10):1751-60. PubMed ID: 21410793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.